Assembly Biosciences Inc (ASMB) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
Assembly Biosciences Inc (ASMB) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($14.24 Million) in capital expenditures ($24.00K). See Assembly Biosciences Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$14.24 Million
USD
Capital Expenditures
$24.00K
USD
Data as of
Dec 2025
Most recent filing
Assembly Biosciences Inc Capital Reinvestment Ratio (2017–2023)
This chart tracks Assembly Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Assembly Biosciences Inc (2017–2023)
Year-by-year Capital Reinvestment Ratio for Assembly Biosciences Inc from 2017 to 2023. For live market cap and broader valuation context, see Assembly Biosciences Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.01x | $22.74 Million | $255.00K | ▼ -97.6% |
| 2017 | 0.46x | $1.86 Million | $864.56K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow